Boehringer Ingelheim Venture Fund

United States
Firm Location:United States • Connecticut • San Francisco, California • Cambridge, Massachusetts • Hong Kong • Shanghai • San Francisco Bay Area • Germany
Boehringer Ingelheim Venture Fund Team
Photo of Yifang Cui, Investor at Boehringer Ingelheim Venture Fund
Yifang Cui
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Germany
Photo of Niklas Czeloth, Investor at Boehringer Ingelheim Venture Fund
Niklas Czeloth
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Germany
Photo of Kanad Das, Investor at Boehringer Ingelheim Venture Fund
Kanad Das
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in San Francisco (CA)
Photo of Alexander Ehlgen, Investor at Boehringer Ingelheim Venture Fund
Alexander Ehlgen
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Israel, Investors in Europe
Photo of Mia Hu, Associate at Boehringer Ingelheim Venture Fund
Mia Hu
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Hong Kong
Photo of Frank Kalkbrenner, Investor at Boehringer Ingelheim Venture Fund
Frank Kalkbrenner
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Germany
Investors in BioTech (Series B)
Photo of Julia Kaufman, Investor at Boehringer Ingelheim Venture Fund
Julia Kaufman
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in United States
Photo of Sebastian Kreuz, Managing Director at Boehringer Ingelheim Venture Fund
Sebastian Kreuz
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Germany
Photo of Hongmei Li, Investor at Boehringer Ingelheim Venture Fund
Hongmei Li
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Shanghai
Photo of Debbie Lin, Investor at Boehringer Ingelheim Venture Fund
Debbie Lin
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Philipp Mueller, Investor at Boehringer Ingelheim Venture Fund
Philipp Mueller
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Germany
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A)
Photo of Stefan Pflanz, Investor at Boehringer Ingelheim Venture Fund
Stefan Pflanz
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in San Francisco (CA)
Photo of Mark Ralph, Investor at Boehringer Ingelheim Venture Fund
Mark Ralph
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Boston (MA)
Photo of Oliver Reuss, Investor at Boehringer Ingelheim Venture Fund
Oliver Reuss
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Germany
Photo of Fei Shen, Managing Director at Boehringer Ingelheim Venture Fund
Fei Shen
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Cambridge (MA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)
Photo of Johannes Zanzinger, Investor at Boehringer Ingelheim Venture Fund
Johannes Zanzinger
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Germany